Research article summary (published 13 Oct 2009):

Chronic natural killer-cell lymphocytosis successfully treated with alemtuzumab.

Full Abstract

No abstract is available for this article. See 'Journal and Publication Information' further down the page for details that may assist you in locating this article in electronic or hard copy media. The 'Related articles' section also further down the page, where available, may show links to abstracts of articles covering similar topics.

Author information

Author/s: Chee, Cheng E (CE); Warrington, Kenneth J (KJ); Tefferi, Ayalew (A);

Journal and publication information

Publication Type: Case Reports; Letter

Journal: Blood (Blood), published in United States. (Language: eng)

Reference: 2009-Oct; vol 114 (issue 16) : pp 3500-2

Dates: Created 2009/10/16; Completed 2009/11/06;

PMID: 19833855, status: MEDLINE (last retrieval date: 11/6/2009, IMS Date: )

Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.

External Links for this article
(including full text providers, if available):

Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.

This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.

MeSH headings (categories)

This article was linked to the MESH Headings shown below.

Aged Antibodies, Monoclonal - administration & dosage Antibodies, Neoplasm - administration & dosage Antineoplastic Agents - administration & dosage Chronic Disease Humans

Killer Cells, Natural Livedo Reticularis - blood; diagnosis; drug therapy; pathology Lymphocytosis - blood; diagnosis; drug therapy; pathology Male Polyarteritis Nodosa - blood; diagnosis; drug therapy; pathology Remission Induction

Associated Chemicals: Antibodies, Monoclonal (0) ; Antibodies, Neoplasm (0) ; Antineoplastic Agents (0) ; alemtuzumab (0)

Related articles

These are the highest related articles currently in the database:

• A 61-year-old man with livedo reticularis. 13 Nov 2008
• Chimerism does not predict for outcome after alemtuzumab-based conditioning: lineage-specific analysis of chimerism of specific diseases may be more informative. 24 Nov 2007
• Monoclonal antibodies for the treatment of hematologic malignancies: schedule and maintenance therapy. 30 Mar 2008
• Prolonged remission in a case of Richter's transformation of B-cell chronic lymphocytic leukaemia following adoptive immunotherapy. 30 Aug 2006
• Reduced-intensity conditioning containing low-dose alemtuzumab before allogeneic peripheral blood stem cell transplantation: graft-versus-host disease is decreased but T-cell reconstitution is delayed. 30 Jul 2005
• Tumor-directed targeting of liposomes. 30 Mar 2002
• Technology evaluation: CC49 humanized radioimmunoconjugates, National Cancer Institute. 30 Jul 2003
• Durable hematologic complete response and suppression of HTLV-1 viral load following alemtuzumab in zidovudine/IFN-{alpha}-refractory adult T-cell leukemia. 31 Jul 2005
• Adefovir added to lamivudine for hepatitis B recurrent infection in refractory B-cell chronic lymphocytic leukemia on prolonged therapy with Campath-1H. 26 Nov 2005
• Cellular immune reconstitution after subcutaneous alemtuzumab (anti-CD52 monoclonal antibody, CAMPATH-1H) treatment as first-line therapy for B-cell chronic lymphocytic leukaemia. 28 Feb 2004

See 100+ related articles.

Related Article Map

Legend: - FREE Full text Article. - Abstract only. - Title only. More help.

See a large map of 100+ related articles.